Identification of ligands selective for central I2-imidazoline binding sites

A. L. Hudson, C. B. Chapleo, J. W. Lewis, S. Husbands, K. Grivas, N. J. Mallard, D. J. Nutt

Research output: Contribution to journalArticlepeer-review

38 Citations (SciVal)


Using radioligand binding techniques, several compounds selective for mammalian brain imidazoline, receptors have been identified. In rabbit brain membranes, a series of 6 and/or 7 aromatic-substituted derivatives of the α2-adrenoceptor antagonist idazoxan were found to show moderate affinity for I2 receptors over α2-adrenoceptors, in particular 6,7-dichloroidazoxan, which was 41 fold selective in favour of I2 receptors. Modification of the benzodioxan ring of idazoxan could also result in affinity and selectivity, which was moderate (2.7 nM, 161 fold) in the case of the 1,3-benzodioxan isomer of idazoxan (2-(1,3-benzodioxanyl)-2-imidazoline), and high (1.3 nM, 2873 fold) in the case of 2-(2-benzofuranyl-2-imidazoline) (2-BFI). Analogues of 2-BFI with halogenic substitutions of the aromatic ring were also found to retain high affinity and moderate to high selectivity for I2-sites. In particular, the 7-chloro (Ki 2.8 nM, 2192 fold) and the 4,6-dibromo (Ki 6.1 nM, 361 fold) analogues of 2-BFI. These new ligands should prove invaluable for investigating the pharmacology and physiology of I2 receptors.

Original languageEnglish
Pages (from-to)47-53
Number of pages7
JournalNeurochemistry International
Issue number1
Publication statusPublished - 1 Jan 1997

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology


Dive into the research topics of 'Identification of ligands selective for central I2-imidazoline binding sites'. Together they form a unique fingerprint.

Cite this